TrialSignal
Clinical trial intelligence report
Feasibility and Safety of a Telemedically Performed Three-Component Oculomotor Testing Battery (HINTS) in Healthy Adults
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 24, 2026
Report code
NCT02938221-Jun 24, 2026
NCT ID
NCT02938221
Status
COMPLETED
Phase
Completed
Sponsor
Munich Municipal Hospital
Executive brief
Investment-Ready Snapshot
The study conducted by Munich Municipal Hospital evaluates the feasibility and safety of a telemedical approach to performing the HINTS protocol, which is critical for diagnosing acute vestibular syndrome. Given the increasing demand for telemedicine solutions, especially in remote areas with limited access to specialists, this asset positions itself well in the growing telehealth market. The successful implementation of this technology could lead to significant commercial opportunities, particularly in neurology and emergency medicine. The competitive landscape includes traditional diagnostic methods and emerging telehealth solutions; thus, demonstrating superior accuracy and safety will be essential for market penetration. Diligence should focus on regulatory pathways and reimbursement strategies for telemedical services.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT02938221
Indication
Stroke
Modality
medical device
Target
Oculomotor function assessment in acute vestibular syndrome.
Intervention
Telemedical video-oculography system
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.